Accurately distinguishing between apoptosis and necrosis is critical in biomedical research, drug development, and disease pathology studies.
This article provides a comprehensive framework for researchers and drug development professionals grappling with the challenge of inconsistent cytochrome c release measurements, a critical step in assessing mitochondrial apoptosis.
This article provides a comprehensive resource for researchers and drug development professionals on optimizing death receptor-mediated extrinsic apoptosis.
This article provides researchers, scientists, and drug development professionals with a comprehensive guide to using Western blotting for distinguishing between the intrinsic and extrinsic apoptotic pathways.
This article provides researchers, scientists, and drug development professionals with a comprehensive resource on detecting mitochondrial membrane potential (MMP) changes during apoptosis.
This article comprehensively reviews BH3 mimetics, a transformative class of small-molecule inhibitors that target anti-apoptotic BCL-2 family proteins to reactivate intrinsic apoptosis in cancer cells.
This article provides a comprehensive overview of strategies to inhibit apoptosis using caspase inhibitors, tailored for researchers and drug development professionals.
This article provides a comprehensive resource for researchers and drug development professionals on the current methodologies for measuring caspase-8 activation in the extrinsic apoptotic pathway.
This article provides a comprehensive resource for researchers and drug development professionals on the TUNEL assay, a cornerstone technique for detecting DNA fragmentation during late-stage apoptosis.
The release of cytochrome c from the mitochondria is a definitive, point-of-no-return event in the intrinsic apoptotic pathway, serving as a critical biomarker for basic research and drug development.